BACKGROUND:Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To move hESCs towards the clinic it is important that cells with therapeutic potential be reproducibly generated under completely defined conditions. METHODOLOGY/PRINCIPAL FINDINGS:Here we report a four-step scalable process that is readily transferable to a Good Manufacture Practice (GMP) facility for the production of functional dopaminergic neurons from hESCs for potential clinical uses. We show that each of the steps (propagation of ESC-->generation of neural stem cells (NSC)-->induction of dopaminergic precursors-->maturation of dopaminergic neurons) could utilize xeno-free defined media and substrate, and that cells could be sto...
International audienceTo find a safe source for dopaminergic neurons, we generated neural progenitor...
BACKGROUND: Neurons and glial cells can be efficiently induced from mouse embryonic stem (ES) cells ...
Our ability to use human embryonic stem (hES) cells in cell replacement therapy for Parkinson’s dise...
Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To ...
Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To ...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
he capacity of pluripotency and self-renewal of human embryonic stem (hES) cells may provide unlimit...
AIM: To find a safe source for dopaminergic neurons, we generated neural progenitor cell lines from ...
We developed a method for the efficient generation of functional dopaminergic (DA) neurons from huma...
The use of human embryonic stem cells (hESCs) as a source of dopaminergic neurons for Parkinson's di...
Human induced pluripotent stem cells (iPSCs) reprog-rammed from somatic cells represent a promising ...
Here, we describe a xeno-free, feeder-free, and chemically defined protocol for the generation of ve...
International audienceTo find a safe source for dopaminergic neurons, we generated neural progenitor...
International audienceTo find a safe source for dopaminergic neurons, we generated neural progenitor...
BACKGROUND: Neurons and glial cells can be efficiently induced from mouse embryonic stem (ES) cells ...
Our ability to use human embryonic stem (hES) cells in cell replacement therapy for Parkinson’s dise...
Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To ...
Human embryonic stem cells (hESCs) may provide an invaluable resource for regenerative medicine. To ...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are potentially valuable in dr...
he capacity of pluripotency and self-renewal of human embryonic stem (hES) cells may provide unlimit...
AIM: To find a safe source for dopaminergic neurons, we generated neural progenitor cell lines from ...
We developed a method for the efficient generation of functional dopaminergic (DA) neurons from huma...
The use of human embryonic stem cells (hESCs) as a source of dopaminergic neurons for Parkinson's di...
Human induced pluripotent stem cells (iPSCs) reprog-rammed from somatic cells represent a promising ...
Here, we describe a xeno-free, feeder-free, and chemically defined protocol for the generation of ve...
International audienceTo find a safe source for dopaminergic neurons, we generated neural progenitor...
International audienceTo find a safe source for dopaminergic neurons, we generated neural progenitor...
BACKGROUND: Neurons and glial cells can be efficiently induced from mouse embryonic stem (ES) cells ...
Our ability to use human embryonic stem (hES) cells in cell replacement therapy for Parkinson’s dise...